York Space Systems: The Factor Beneath the Crash

YSS, a defense satellite prime that IPO'd at $34 in January 2026, fell from $35 to $24 in three weeks around its Q1 2026 print — down 17% the day of the 10-Q filing alone. The headline is execution failure. The under-told story is a new Pentagon procurement factor that loads on six tickers and a PE sponsor (AE Industrial Partners) assembling ≈$1.3B of vertically integrated mid-tier space prime around YSS.

What the filing says

Q1 2026 revenue $116.3M (+9% YoY) — sharp deceleration from +52% FY2025. Adj EBITDA reversed from +$5.5M (Q1 2025) to -$3.6M. Gross margin compressed 23%→19% from a $5.5M loss contract reserve (first ever) and unfavorable EAC adjustments on two contracts. EPS -$0.68 vs -$0.11 estimate (-497% miss). Management reaffirmed FY2026 guidance $545-595M — requiring ≈$143M/qtr Q2-Q4 against the $116M Q1 base.

Single-customer concentration rose from 94% to 99%. Material weakness in POC revenue-recognition controls — first disclosed in the 2025 10-K — remains unremediated; CEO/CFO confirmed disclosure controls were NOT effective as of March 31, 2026. The weakness is directly connected to the EAC volatility driving the margin compression.

Subsequent event (8-K April 29, 2026): $355M acquisition of All.Space Holdings (UK-domiciled, formerly Isotropic Systems), multi-network SATCOM terminals — pending UK foreign-investment review. Cash position $655.7M, revolver undrawn, net cash positive.

What the market thinks

Analyst mean target $35.22 (range $26-45) — but 9 of 10 analysts have NOT updated post-Q1 (only Goldman cut to Neutral $31 on Apr 20). Realistic post-revision consensus probably $25-30. Options positioning: P/C volume 48; 4,025 puts at the $20 strike (vs zero open interest prior). Max pain $18. ATM IV 119.7% with OTM put skew +39.7%. Idio vol 126%.

Probability-weighted 12mo E[r] ≈ +3.25% on the single name. SR ≈ 0.05. The single-name risk-reward fights bearish option flow without compensating asymmetry.

Why the gap exists

The single-name lens misses three things sell-side won't synthesize:

1. SDA is being dissolved. Acting director Sandhoo (Apr 15) and USSF Brig. Gen. Fernengel (May 14) publicly confirmed SDA folds into the Pentagon's Portfolio Acquisition Executive structure. Transport Layer → "Space Data Network." FY2027 budget: $1.485B for SDN, with $800M explicitly designated to on-ramp ADDITIONAL commercial vendors. Incumbent primes (LMT, NOC, LHX) were silent in Q1 disclosures — the mandatory-vs-voluntary disclosure asymmetry typical of incumbents quiet on disruptors. IRDM is the only public name explicitly self-positioning as SDN beneficiary on its Q1 call.

2. AE Industrial is assembling a platform. YSS's PE sponsor has committed ≈$1.3B in six months: Orbion (propulsion, closed March), All.Space (terminals, pending H2 2026), Atlas Space Operations (ground), and the L3Harris SPPS/SA&C carve-out ($845M, closing H2 2026). AEI's consulting fee with YSS terminates at <10% ownership — explicit economic alignment to hold above threshold past the July 29 lockup. Target exit: 2027-2028 re-IPO or strategic sale of the integrated platform.

3. The Tranche 1 software issue isn't YSS. Aviation Week, DefenseScoop, and Air & Space Forces (March 2026) attributed the on-orbit software readiness issue causing ≈4-month SDA Tr1 launch delay to NOC, not YSS. NOC was silent on the issue in its Q1 10-Q. EAC charges typically surface 1-2 quarters after acknowledgment — an asymmetric short option on NOC space margins, decorrelated from the YSS thesis.

Risks (ranked)

1. Material weakness → restatement. Unremediated >12 months. If extends to year-end 2026, restatement risk (8-K Item 4.02) becomes material.
2. 99% single-customer concentration into procurement reorganization. Even if SDN on-ramp lands, transition risk to existing book is real.
3. PE lockup expiry July 29. AEI's consulting structure aligns AEI but not its LPs — distribution pressure independent of AEI intent. Options market positioned at $20.
4. Q2 guidance credibility. $143M/qtr required from $116M base with no specific catalyst disclosed.
5. All.Space UK regulatory close. NSIA review historically 6-12 months on defense-sensitive IP (7mo precedent: Mynaric/RKLB).

Catalysts

• Jul 29, 2026 — PE lockup expiry
• Aug 12, 2026 — Q2 2026 earnings (revenue inflection test)
• H2 2026 — All.Space + LHX SPPS/SA&C closes (AE platform crystallizes)
• Nov 2026 — Q3 2026 earnings (material weakness remediation check)
• Dec 2026 - Mar 2027 — FY2027 appropriations / SDN $800M on-ramp confirmation
• Q1 2027 — First named SDN task orders

What would change our mind

• AE Industrial 13D/A post-lockup showing accumulation, not distribution → platform thesis confirmed
• Named SDN task order to YSS → factor thesis confirmed
• Q2 print ≥$135M with material weakness remediation progress → execution thesis confirmed
• AE Industrial S-3 with distribution language → platform thesis broken
• Material weakness extends to 2026 10-K → restatement risk priced
• Tr1 software issue publicly attributed to YSS (not NOC) → idio bear cascade

Evidence